S
Scott M. Grundy
Researcher at University of Texas Southwestern Medical Center
Publications - 849
Citations - 246629
Scott M. Grundy is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 187, co-authored 841 publications receiving 231821 citations. Previous affiliations of Scott M. Grundy include University of California, San Francisco & University of California, Davis.
Papers
More filters
Journal ArticleDOI
Cholesterol issues as viewed from the United States
TL;DR: The campaign of public education about cholesterol carried out by the NCEP and affiliated organizations has produced tangible results for the general public, and the average level of serum cholesterol has declined progressively since the introduction of the programme.
Journal ArticleDOI
Statin therapy for primary prevention in women: What is the role for coronary artery calcium?
Scott M. Grundy,Gloria Lena Vega +1 more
TL;DR: Baigent et al. as mentioned in this paper conducted a meta-analysis of data from 170,000 participants in 26 randomised trials and concluded that statin therapy has potential to markedly reduce risk for atherosclerotic cardiovascular disease (ASCVD).
Journal Article
International Conference on New Approaches to Dietary Management of Elevated Cholesterol, Dublin, 28th-30th January 1999: Foreword
Journal ArticleDOI
[Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].
Scott M. Grundy,Hidenori Arai,Philip J. Barter,Thomas P. Bersot,D. John Betteridge,Rafael Carmena,Ada Cuevas,Michael H. Davidson,Jacques Genest,Y. Antero Kesäniemi,Shaukat Sadikot,Raul D. Santos,Andrey V. Susekov,Rody G. Sy,Lale Tokgozoglu,Gerald F. Watts,Dong Zhao +16 more
TL;DR: La Sociedad Internacional de Aterosclerosis (IAS) ha actualizado sus recomendaciones para el tratamiento de la hipercolesterolemia and the dislipidemia with el propósito de contribuir a la reducción del riesgo of las enfermedades cardiovasculares de origen arteriosclerótico.